Ming Q. Wei

Ming Q. Wei

Auto-generated profile, based on publicly available information

Ming Q. Wei

Division of Molecular and Gene Therapies, Griffith Health Institute and School of Medical Science, Griffith University, Gold Coast, QLD 4222, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Cancer Letters
Verified
Journal Article
Closed access
MWMing Q Wei
Ming Q Wei
AMAsferd Mengesha
Asferd Mengesha
DGDavid Good
David Good
JAJozef Anné
Jozef Anné

1 February 2007 in European Journal of Cancer
Verified
Journal Article
Closed access
MWMing Q. Wei
Ming Q. Wei
KEKay A.O. Ellem
Kay A.O. Ellem
PDPaul Dunn
Paul Dunn
MWMalcolm J. West
Malcolm J. West
CBChun Xue Bai
Chun Xue Bai
BVBert Vogelstein
Bert Vogelstein

1 January 2013 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CLChun Li
Chun Li
SHSaeed Mujahid Hashimi
Saeed Mujahid Hashimi
SCSiyu Cao
Siyu Cao
AMAlbert Sleiman Mellick
Albert Sleiman Mellick
WDWei Duan
Wei Duan
MWMing Q. Wei
Ming Q. Wei
Chansu is one of the most widely used traditional Chinese medicines in China, Japan, and other Southeast Asian countries primarily for antipain, anti-inflammation, and recently anticancer. Over 10 recipes and remedies contained Chansu, which are easily available in pharmacies and hospitals, but the mechanisms of action were not clearly articulated. In the present study, Cinobufagin (CBF), the major compound of Chansu, was employed as a surrogate marker to determine its ability in inducing cancer cell death. As expected, CBF has significant cancer-killing capacity for a range of cancers, but such ability differs markedly. Colon and prostate cancers are more sensitive than skin and lung cancers. Interestingly, cancer cells die through apoptotic pathway either being biphasic caspase-3-dependent (HCT116) or independent (HT29). Multipathway analysis reveals that CBF-induced apoptosis is likely modulated by the hypoxia-inducing factor-1 alpha subunit (HIF-1α) as its inhibition was evidentin vitroandin vivo. Taken together, these results demonstrate that CBF is a potent apoptotic inducer with potential for further development as a novel and effective anticancer agent for a range of cancers, especially colon cancer.